Mild Cognitive Impairment (MCI) Clinical Trial
Official title:
Computer-based Sensory-cognitive and Physical Fitness Training in Mild Cognitive Impairment (MCI) and Mild Alzheimer's Disease (AD)
Age-related cognitive decline is unavoidable. However, recent results of
neuroplasticity-based research show that neuroplasticity-based training and physical
activity might have the potential to decelerate or even reverse effects of aging and
age-related cognitive impairments. Little is known whether these results also apply to
pathological processes of aging such as mild cognitive impairment (MCI) and dementia.
This multi-center study aims at investigating efficiency and feasibility of a
neuroplasticity-based auditory discrimination training and a physical fitness training for
patients suffering from mild cognitive impairment or mild Alzheimer's disease (Mini Mental
State Examination, MMSE > 19). Evaluation will include neuropsychological testing,
electroencephalography (EEG) and magnetic resonance imaging (MRI) measurements as well as
blood and liquor analyses.
n/a
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00934531 -
Donepezil and the Risk of Falls in Seniors With Cognitive Impairment
|
N/A | |
Withdrawn |
NCT05033912 -
A Study of CST-2032 in Subjects With Cognitive Impairment
|
Phase 1 | |
Recruiting |
NCT02854033 -
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
|
||
Completed |
NCT01902004 -
Brain Aging and Treatment Response in Geriatric Depression
|
Phase 4 | |
Completed |
NCT01212692 -
Effects of Mental Stimulation in Patients With Mild Cognitive Impairment
|
Phase 2 | |
Recruiting |
NCT00544791 -
The Effect of Melatonin on Cognitive Function in Patients Diagnosed With Mild Cognitive Impairment
|
Phase 2 | |
Withdrawn |
NCT04055532 -
Biomarkers in Neurodegenerative Diseases
|
||
Terminated |
NCT02180529 -
The Effects of Methylphenidate on the Cognitive Function of Older People With Mild Cognitive Impairment
|
N/A | |
Completed |
NCT05108922 -
A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)
|
Phase 3 | |
Recruiting |
NCT05865340 -
To Exam the Efficacy of Oral Health and Mediterranean Diet Interventions in Preventing Cognitive Decline Among Older Adults With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT06453941 -
Yizhi Baduanjin for Patients With Cognitive Impairment
|
N/A | |
Completed |
NCT06417034 -
Hand Training Device For Cognitive Care
|
N/A | |
Completed |
NCT02110043 -
Modulation of Visual-Spatial Learning in Patients With Mild Cognitive Impairment (MCI) by tDCS
|
N/A | |
Completed |
NCT01383161 -
18-Month Study of Memory Effects of Curcumin
|
Phase 2 | |
Completed |
NCT01299766 -
Preventing Cognitive Decline in African Americans With Mild Cognitive Impairment
|
Phase 3 | |
Withdrawn |
NCT05321498 -
Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation
|
Phase 2 | |
Completed |
NCT04748666 -
PST for Care Partners of Adults With Alzheimer's and Alzheimer'S-related Dementia
|
N/A | |
Recruiting |
NCT03138018 -
Aging Stereotypes and Prodromal Alzheimer's Disease
|
N/A | |
Withdrawn |
NCT01891383 -
Clinical Characteristics of Dementias That Occur Remotely After Traumatic Brain Injury in Retired Military Personnel
|
||
Recruiting |
NCT03448055 -
Nutritional Intervention With the Dietary Supplement, Immunocal® in MCI Patients: Promotion of Brain Health
|
N/A |